Full Text
Full text is available in PDF
Background:
Dyslipidemia after kidney transplantation is a frequent finding and is multifactorial. Immunosuppressive agents such as cyclosporine (CsA) can cause hypercholesterolemia.
Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level
1Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
*Corresponding Author: Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran. Tel: +98-2188037560, Fax: +98-2181263989, m_hosseini440@yahoo.com. Email: m_hosseini440@yahoo.com
Published online:Jun 13, 2013
Article type:Research Article
Received:Apr 30, 2013
Accepted:May 14, 2013
Abstract
Objectives:
As there were few reports with conflicting evidence on whether CsA related dyslipidemia is dose related and that CsA monitoring assays (trough level, C0, or two hour post dose level, C2) is a better predictor for dyslipidemia development; hence, the current study, in a large sample size, was designed to answer these questions.
3. Patients and Methods:
In the current retrospective cross sectional study, 1391 kidney transplant recipients were enrolled. All patients received CsA plus mycophenolatemofetile or azathioprine and prednisolone. Serum creatinine, CsA blood levels and lipid profile were measured after 12-14 h fasting. Mann-Whitney and Kruskal-Wallis, Pearson`s test and logistic regression were used for data analyses.
Results:
Mean age of 1391studied population was 38.7 15 years old. Hypercholesterolemia and hypertriglyceridemia were observed in 58.9% and 86.6%, respectively and they were more significantly detected in cadaveric kidney transplantation. Dyslipidemia had weak correlation with age of recipient, serum creatinine, C0 and C2 levels of CsA. At logistic regression, serum creatinine was the only risk factor for hypercholesterolemia development after kidney transplantation (OR = 1.6, CI 95%: 1.4 -1.8).
Conclusions:
Dyslipidemia is a common finding after kidney transplantation and has no correlation with CsA level. According to conflicting data on the precise effect of different factors in inducing dyslipidemia, prospective large sample size studies should consider better control of dyslipidemia.
Highlights
How to Cite:Hosseini M, Rostami Z, Einollahi B. Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level. Nephro-Urol Mon. 2013;5(3):. doi: https://doi.org/10.5812/numonthly.11890
Copyright
© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
29
Oct
2013
Dyslipidemia in Renal Transplant Recipients Treated With Cyclosporine A
Mariusz Niemczyk
Niemczyk M. Dyslipidemia in Renal Transplant Recipients Treated With Cyclosporine A. Nephro-Urol Mon. 2013;5(5):1005-1005. doi: https://doi.org/10.5812/numonthly.14167
13
Nov
2013
Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level: A Glimpse into the Future
Mohamed H. Ahmed
Ahmed MH. Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level: A Glimpse into the Future. Nephro-Urol Mon. 2013;5(5):1006-1007. doi: https://doi.org/10.5812/numonthly.14179
13
Jan
2014
No Association Between Cyclosporine Levels and Dyslipidemia?
Guido Filler
Filler G. No Association Between Cyclosporine Levels and Dyslipidemia?. Nephro-Urol Mon. 2014;6(1):e14296. doi: https://doi.org/10.5812/numonthly.14296
1
Mar
2012
Change of Cyclosporine Absorption over the Time After Kidney Transplantation
Behzad Einollahi,
Mojtaba Teimoori,
Zohreh Rostami
Einollahi B, Teimoori M, Rostami Z. Change of Cyclosporine Absorption over the Time After Kidney Transplantation. Nephro-Urol Mon. 2012;4(2):470-474. doi: https://doi.org/10.5812/numonthly.2437
11
Mar
2017
A Systematic Review about an Advance in Cyclosporine Monitoring in Kidney Transplant Recipients
Behzad Einollahi,
Mojtaba Teimoori
Einollahi B, Teimoori M. A Systematic Review about an Advance in Cyclosporine Monitoring in Kidney Transplant Recipients. Nephro-Urol Mon. 2017;9(4):e24989. doi: https://doi.org/10.5812/numonthly.24989
More by these authors
Cited by
- Scopus by DOI: 9
Last Update: 1 month ago
- Scopus by Title: 9
Last Update: 1 month ago
- Scopus by Title (Ref): 9
Last Update: 1 month ago
- CrossRef: 7
Last Update: 4 days ago
- OpenAlex: 13
Last Update: 2 days ago
- OpenCitations: 9
Last Update: 2 days ago
Comments
Number of Comments:0Indexed in
